Currently, no gene therapy for CSNB2 is available. However, Waldner and colleagues established a mouse line that showed a partial structural and functional rescue of retinal integrity by cre-induced expression of a transgenic Cav1.4 [104]. Cre expression was controlled by a Pax6 promoter, resultin...